tirzepatide for cardiovascular disease

tirzepatide for cardiovascular disease Cardiorenal Outcomes With Compared With Dulaglutide in Patients With Diabetes and A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial Compared with the GLP-1 agonist dulaglutide, the dual SURPASS-CVOT Published: Large Trial Confirms

Name: tirzepatide for cardiovascular disease Cardiorenal Outcomes With Compared With Dulaglutide in Patients With Diabetes and A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical Trial Compared with the GLP-1 agonist dulaglutide, the dual SURPASS-CVOT Published: Large Trial Confirms
Brand: actil.am
SKU: 54727004899
Price: 28.96 USD
Availability: InStock
Rating: 4.2574000000000005 (30 reviews)

SKU: 54727004899

4.3

USD28.96 USD58.96

Pay in 4 interest-free payments of $7.24 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 1 - Sep 6

Description

When participants returned to the living room lab at the end of the study, those taking semaglutide drank about 40 per cent less alcohol than those on placebo, the study found